Pulse Biosciences, Inc. (PLSE) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of Pulse Biosciences, Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PLSE vs RGC

growth of $100 · dividends reinvested · last 5y
PLSE +179.6% (+22.8%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
1101001k10k100kStart $10020222023202420252026$280$2,620
PLSE RGC

PLSE vs RGC: by the numbers

  • •RGC is the larger company ($3.64B vs $3.44B market cap).
  • •Both run net losses; RGC's is the smaller (0.00% vs -6755.78% net margin).

Metrics side by side

Valuation

MetricPLSERGC
P/S ratio2905.64N/A
P/B ratio34.602986.54

Profitability

MetricPLSERGC
Gross margin-360.00%0.00%
Operating margin-21982.57%0.00%
Net margin-6755.78%0.00%
ROE-80.46%-73.75%
ROIC-79.40%-69.75%

Growth (annualized)

MetricPLSERGC
Total return CAGR (5Y)19.76%67.94%

Frequently asked

How have PLSE and RGC total returns compared?
Over the past 5 years, PLSE delivered 19.76% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.